Prof Saul Faust, co-study leader at the University of Southampton and a consultant paediatrician, said: “These latest results show that this long-acting antibody is safe and could protect thousands of babies from hospitalisation when used in conditions similar to routine clinical practice. It is really important information for the UK to help decide on options for the future national RSV immunisation programme.”
Trending
- Donald Trump threatens to revoke Rosie O’Donnell’s US citizenship | US News
- Why Rami Al Ali’s official couture debut is a defining moment for Arab fashion
- Patsy Kensit – News, views, pictures, video
- Video: See how this artist transforms into hundreds of people
- This H&M dress is sold out before the end of the month
- Nvidia becomes world’s first $4tn company
- Mystery space rock blazing through solar system ‘may be oldest comet ever seen’ – and there’s a chance you can spot it
- Simon heeft ongeneeslijk kanker, maar doet wat hij kan: ‘Geen bucketlist, maar een fuck it-list’
